Bronchogen
Lungs & airways Research only Animal studies Synthetic short peptide (Cytogen)
Also called AEDL peptide
A four-amino-acid Khavinson peptide associated with the lining of the bronchi. It is studied for effects on gene expression in bronchial epithelial cells, including DNA binding and promoter methylation.
Evidence at a glance
- Evidence
- Animal studies — Not yet studied in people
- Status
- Research compound only
- Dosing
- No human study has set a dose
Cell-culture work from the St Petersburg institute that developed it. No independent human data.
What studies report
- Effects on gene expression in bronchial epithelial cell cultures
- Studied in DNA binding and promoter methylation assays
How it works
A Khavinson short peptide: at two to four amino acids it is small enough to pass through cell and nuclear membranes intact. The proposed mechanism is that it binds specific sites on nuclear DNA and changes which genes are switched on in its target tissue, rather than acting on a surface receptor the way most peptides do.
Where it acts
LungsThe library groups this compound under Lungs & airways. The diagram shows that target, not every tissue it reaches.
Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
Status: Research compound. Not approved.
- Route
- Subcutaneous injection, or oral capsule depending on the preparation
- Sequence
- Ala-Glu-Asp-Leu
- Formula
- C18H30N4O9
- Molecular weight
- 446.5 g/mol
- CAS
- 857267-12-0
- Available as
- 20 mg
Search PubMed for Bronchogen → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.